Categories: Financial Results

Piramal Enterprises posts Rs.11 crore net loss


Mumbai January 31, 2014: Piramal Enterprises Ltd on Thursday posted a net loss of Rs.11 crore for the December quarter on increased finance costs and tax expenses, although total income rose almost 30% to Rs.1,305 crore.
The Ajay Piramal-led pharmaceuticals-to-financial services group had made a net profit of Rs.61 crore in the corresponding year-ago quarter.
Piramal Enterprises had acquired the rights to own and sell the over-the-counter skincare brand Caladryl from Valeant Pharmaceuticals International Inc. in the local market in November. This, along with the debt it raised to acquire US-based drug industry analytics firm Decision Resources Group in 2013 contributed to the almost 100% rise in financial costs.
The company had also raised funds for its financial services business, which includes corporate funding in the realty sector and private equity business.
“The figures for the December quarter are not actually comparable to the year-ago quarter on account of acquisition of Decision Resources Group in June 2012,” Piramal Enterprises said.-Livemint
The Pharma Times News Bureau

Recent Posts

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

17 hours ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

17 hours ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

1 day ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

1 day ago

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

3 days ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

3 days ago